Table 2.
Comparison of the mean values of immunological characteristics between patients with tumors positive or negative for HPV (for details see materials and methods).
| Immunological characteristics | HPV + | HPV − | P value | 95% CI | P value adja | 95% CI adja |
|---|---|---|---|---|---|---|
| Mean | Mean | |||||
| CD8+ (%) | 26.6 | 26.8 | 0.896 | −3.8; 4.3 | 0.846 | 0.9; 1.1 |
| CD4+ (%) | 44.3 | 48.0 | 0.085 | −0.5; 7.9 | 0.199 | 0.9; 1.0 |
| CD19+ (%) | 11.3 | 4.7 | 0.332 | −4.4; 1.5 | 0.305 | 1.0; 1.2 |
| CD3−CD56+16+ (%) | 13.6 | 6.4 | 0.005 | −7.2; −1.3 | 0.052 | 1.0; 1.3 |
| CD4+/CD8+ | 1.8 | 2.1 | 0.355 | 0.1; 7.8 | 0.451 | 0.4; 1.5 |
| Tregs (%) | 15.9 | 15.8 | 0.998 | −4.6; 4.6 | 0.924 | 0.9; 1.1 |
| CD8+CD4+sum | 70.9 | 74.8 | 0.355 | 0.1; 7.8 | 0.116 | 0.9; 1.0 |
| CD8+/Tregs | 2.4 | 3.5 | 0.258 | −0.8; 3.0 | 0.455 | 0.7; 1.1 |
aadjusted for age.
95% CI: confidence interval; P: probability.